Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
17,819
archived clinical trials in
Brain Cancer

Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated:  1/11/2018
Sarah Cannon Research Institute
mi
from
Nashville, TN
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated: 1/11/2018
Sarah Cannon Research Institute
mi
from
Nashville, TN
Click here to add this to my saved trials
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated:  1/11/2018
Vanderbilt-Ingram Cancer Center
mi
from
Nashville, TN
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated: 1/11/2018
Vanderbilt-Ingram Cancer Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated:  1/11/2018
Texas Oncology Midtwon
mi
from
Austin, TX
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated: 1/11/2018
Texas Oncology Midtwon
mi
from
Austin, TX
Click here to add this to my saved trials
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated:  1/11/2018
Baylor Research Institute
mi
from
Dallas, TX
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated: 1/11/2018
Baylor Research Institute
mi
from
Dallas, TX
Click here to add this to my saved trials
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated:  1/11/2018
Methodist Neurological Institute
mi
from
Houston, TX
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated: 1/11/2018
Methodist Neurological Institute
mi
from
Houston, TX
Click here to add this to my saved trials
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated:  1/11/2018
University of Utah Department of Neurosurgery
mi
from
Salt Lake City, UT
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated: 1/11/2018
University of Utah Department of Neurosurgery
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated:  1/11/2018
Fletcher Allen Health Care
mi
from
Burlington, VT
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated: 1/11/2018
Fletcher Allen Health Care
mi
from
Burlington, VT
Click here to add this to my saved trials
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated:  1/11/2018
University of Virginia Healthcare System
mi
from
Charlottesville, VA
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated: 1/11/2018
University of Virginia Healthcare System
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated:  1/11/2018
Swedish Neuroscience Institute
mi
from
Seattle, WA
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated: 1/11/2018
Swedish Neuroscience Institute
mi
from
Seattle, WA
Click here to add this to my saved trials
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated:  1/11/2018
University of Washington Medical Center
mi
from
Seattle, WA
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated: 1/11/2018
University of Washington Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated:  1/11/2018
Medical College of Wisconsin
mi
from
Milwaukee, WI
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated: 1/11/2018
Medical College of Wisconsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated:  1/11/2018
University of California at San Francisco
mi
from
San Francisco, CA
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated: 1/11/2018
University of California at San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated:  1/11/2018
University of Massachusetts Memorial Medical Center
mi
from
Worcester, MA
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated: 1/11/2018
University of Massachusetts Memorial Medical Center
mi
from
Worcester, MA
Click here to add this to my saved trials
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated:  1/11/2018
Weill-Cornell Medical College
mi
from
New York, NY
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated: 1/11/2018
Weill-Cornell Medical College
mi
from
New York, NY
Click here to add this to my saved trials
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated:  1/11/2018
SUNY Upstate Medical University
mi
from
Syracuse, NY
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated: 1/11/2018
SUNY Upstate Medical University
mi
from
Syracuse, NY
Click here to add this to my saved trials
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated:  1/11/2018
University of Wisconsin Paul P. Carbone Comprehensive Cancer Center
mi
from
Madison, WI
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated: 1/11/2018
University of Wisconsin Paul P. Carbone Comprehensive Cancer Center
mi
from
Madison, WI
Click here to add this to my saved trials
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated:  1/11/2018
Prince of Wales Hospital
mi
from
Randwick,
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated: 1/11/2018
Prince of Wales Hospital
mi
from
Randwick,
Click here to add this to my saved trials
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated:  1/11/2018
Washington University in St. Louis
mi
from
Saint Louis, MO
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated: 1/11/2018
Washington University in St. Louis
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated:  1/11/2018
West Penn Allegheny Health System
mi
from
Pittsburgh, PA
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Status: Enrolling
Updated: 1/11/2018
West Penn Allegheny Health System
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Phase II Study of Rindopepimut (CDX-110) in Patients With Glioblastoma Multiforme
A Phase II Study of CDX-110 With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme
Status: Enrolling
Updated:  1/11/2018
Celldex Investigational Site
mi
from
Orange, CA
Phase II Study of Rindopepimut (CDX-110) in Patients With Glioblastoma Multiforme
A Phase II Study of CDX-110 With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme
Status: Enrolling
Updated: 1/11/2018
Celldex Investigational Site
mi
from
Orange, CA
Click here to add this to my saved trials
Phase II Study of Rindopepimut (CDX-110) in Patients With Glioblastoma Multiforme
A Phase II Study of CDX-110 With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme
Status: Enrolling
Updated:  1/11/2018
Celldex Investigational Site
mi
from
San Francisco, CA
Phase II Study of Rindopepimut (CDX-110) in Patients With Glioblastoma Multiforme
A Phase II Study of CDX-110 With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme
Status: Enrolling
Updated: 1/11/2018
Celldex Investigational Site
mi
from
San Francisco, CA
Click here to add this to my saved trials
Phase II Study of Rindopepimut (CDX-110) in Patients With Glioblastoma Multiforme
A Phase II Study of CDX-110 With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme
Status: Enrolling
Updated:  1/11/2018
Celldex Investigational Site
mi
from
Stanford, CA
Phase II Study of Rindopepimut (CDX-110) in Patients With Glioblastoma Multiforme
A Phase II Study of CDX-110 With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme
Status: Enrolling
Updated: 1/11/2018
Celldex Investigational Site
mi
from
Stanford, CA
Click here to add this to my saved trials
Phase II Study of Rindopepimut (CDX-110) in Patients With Glioblastoma Multiforme
A Phase II Study of CDX-110 With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme
Status: Enrolling
Updated:  1/11/2018
Celldex Investigational Site
mi
from
New Haven, CT
Phase II Study of Rindopepimut (CDX-110) in Patients With Glioblastoma Multiforme
A Phase II Study of CDX-110 With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme
Status: Enrolling
Updated: 1/11/2018
Celldex Investigational Site
mi
from
New Haven, CT
Click here to add this to my saved trials
Phase II Study of Rindopepimut (CDX-110) in Patients With Glioblastoma Multiforme
A Phase II Study of CDX-110 With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme
Status: Enrolling
Updated:  1/11/2018
Celldex Investigational Site
mi
from
Gainesville, FL
Phase II Study of Rindopepimut (CDX-110) in Patients With Glioblastoma Multiforme
A Phase II Study of CDX-110 With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme
Status: Enrolling
Updated: 1/11/2018
Celldex Investigational Site
mi
from
Gainesville, FL
Click here to add this to my saved trials
Phase II Study of Rindopepimut (CDX-110) in Patients With Glioblastoma Multiforme
A Phase II Study of CDX-110 With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme
Status: Enrolling
Updated:  1/11/2018
Celldex Investigational Site
mi
from
Chicago, IL
Phase II Study of Rindopepimut (CDX-110) in Patients With Glioblastoma Multiforme
A Phase II Study of CDX-110 With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme
Status: Enrolling
Updated: 1/11/2018
Celldex Investigational Site
mi
from
Chicago, IL
Click here to add this to my saved trials
Phase II Study of Rindopepimut (CDX-110) in Patients With Glioblastoma Multiforme
A Phase II Study of CDX-110 With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme
Status: Enrolling
Updated:  1/11/2018
Celldex Investigational Site
mi
from
Evanston, IL
Phase II Study of Rindopepimut (CDX-110) in Patients With Glioblastoma Multiforme
A Phase II Study of CDX-110 With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme
Status: Enrolling
Updated: 1/11/2018
Celldex Investigational Site
mi
from
Evanston, IL
Click here to add this to my saved trials
Phase II Study of Rindopepimut (CDX-110) in Patients With Glioblastoma Multiforme
A Phase II Study of CDX-110 With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme
Status: Enrolling
Updated:  1/11/2018
Celldex Investigational Site
mi
from
Boston, MA
Phase II Study of Rindopepimut (CDX-110) in Patients With Glioblastoma Multiforme
A Phase II Study of CDX-110 With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme
Status: Enrolling
Updated: 1/11/2018
Celldex Investigational Site
mi
from
Boston, MA
Click here to add this to my saved trials
Phase II Study of Rindopepimut (CDX-110) in Patients With Glioblastoma Multiforme
A Phase II Study of CDX-110 With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme
Status: Enrolling
Updated:  1/11/2018
Celldex Investigational Site
mi
from
Lansing, MI
Phase II Study of Rindopepimut (CDX-110) in Patients With Glioblastoma Multiforme
A Phase II Study of CDX-110 With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme
Status: Enrolling
Updated: 1/11/2018
Celldex Investigational Site
mi
from
Lansing, MI
Click here to add this to my saved trials
Phase II Study of Rindopepimut (CDX-110) in Patients With Glioblastoma Multiforme
A Phase II Study of CDX-110 With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme
Status: Enrolling
Updated:  1/11/2018
Celldex Investigational Site
mi
from
Saginaw, MI
Phase II Study of Rindopepimut (CDX-110) in Patients With Glioblastoma Multiforme
A Phase II Study of CDX-110 With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme
Status: Enrolling
Updated: 1/11/2018
Celldex Investigational Site
mi
from
Saginaw, MI
Click here to add this to my saved trials
Phase II Study of Rindopepimut (CDX-110) in Patients With Glioblastoma Multiforme
A Phase II Study of CDX-110 With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme
Status: Enrolling
Updated:  1/11/2018
Celldex Investigational Site
mi
from
Hackensack, NJ
Phase II Study of Rindopepimut (CDX-110) in Patients With Glioblastoma Multiforme
A Phase II Study of CDX-110 With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme
Status: Enrolling
Updated: 1/11/2018
Celldex Investigational Site
mi
from
Hackensack, NJ
Click here to add this to my saved trials
Phase II Study of Rindopepimut (CDX-110) in Patients With Glioblastoma Multiforme
A Phase II Study of CDX-110 With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme
Status: Enrolling
Updated:  1/11/2018
Celldex Investigational Site
mi
from
Amherst, NY
Phase II Study of Rindopepimut (CDX-110) in Patients With Glioblastoma Multiforme
A Phase II Study of CDX-110 With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme
Status: Enrolling
Updated: 1/11/2018
Celldex Investigational Site
mi
from
Amherst, NY
Click here to add this to my saved trials
Phase II Study of Rindopepimut (CDX-110) in Patients With Glioblastoma Multiforme
A Phase II Study of CDX-110 With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme
Status: Enrolling
Updated:  1/11/2018
Celldex Investigational Site
mi
from
New York, NY
Phase II Study of Rindopepimut (CDX-110) in Patients With Glioblastoma Multiforme
A Phase II Study of CDX-110 With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme
Status: Enrolling
Updated: 1/11/2018
Celldex Investigational Site
mi
from
New York, NY
Click here to add this to my saved trials
Phase II Study of Rindopepimut (CDX-110) in Patients With Glioblastoma Multiforme
A Phase II Study of CDX-110 With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme
Status: Enrolling
Updated:  1/11/2018
Celldex Investigational Site
mi
from
Durham, NC
Phase II Study of Rindopepimut (CDX-110) in Patients With Glioblastoma Multiforme
A Phase II Study of CDX-110 With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme
Status: Enrolling
Updated: 1/11/2018
Celldex Investigational Site
mi
from
Durham, NC
Click here to add this to my saved trials
Phase II Study of Rindopepimut (CDX-110) in Patients With Glioblastoma Multiforme
A Phase II Study of CDX-110 With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme
Status: Enrolling
Updated:  1/11/2018
Celldex Investigational Site
mi
from
Cincinnati, OH
Phase II Study of Rindopepimut (CDX-110) in Patients With Glioblastoma Multiforme
A Phase II Study of CDX-110 With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme
Status: Enrolling
Updated: 1/11/2018
Celldex Investigational Site
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Phase II Study of Rindopepimut (CDX-110) in Patients With Glioblastoma Multiforme
A Phase II Study of CDX-110 With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme
Status: Enrolling
Updated:  1/11/2018
Celldex Investigational Site
mi
from
Cleveland, OH
Phase II Study of Rindopepimut (CDX-110) in Patients With Glioblastoma Multiforme
A Phase II Study of CDX-110 With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme
Status: Enrolling
Updated: 1/11/2018
Celldex Investigational Site
mi
from
Cleveland, OH
Click here to add this to my saved trials
Phase II Study of Rindopepimut (CDX-110) in Patients With Glioblastoma Multiforme
A Phase II Study of CDX-110 With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme
Status: Enrolling
Updated:  1/11/2018
Celldex Investigational Site
mi
from
West Chester, OH
Phase II Study of Rindopepimut (CDX-110) in Patients With Glioblastoma Multiforme
A Phase II Study of CDX-110 With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme
Status: Enrolling
Updated: 1/11/2018
Celldex Investigational Site
mi
from
West Chester, OH
Click here to add this to my saved trials
Phase II Study of Rindopepimut (CDX-110) in Patients With Glioblastoma Multiforme
A Phase II Study of CDX-110 With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme
Status: Enrolling
Updated:  1/11/2018
Celldex Investigational Site
mi
from
Westlake, OH
Phase II Study of Rindopepimut (CDX-110) in Patients With Glioblastoma Multiforme
A Phase II Study of CDX-110 With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme
Status: Enrolling
Updated: 1/11/2018
Celldex Investigational Site
mi
from
Westlake, OH
Click here to add this to my saved trials
Phase II Study of Rindopepimut (CDX-110) in Patients With Glioblastoma Multiforme
A Phase II Study of CDX-110 With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme
Status: Enrolling
Updated:  1/11/2018
Celldex Investigational Site
mi
from
Philadelphia, PA
Phase II Study of Rindopepimut (CDX-110) in Patients With Glioblastoma Multiforme
A Phase II Study of CDX-110 With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme
Status: Enrolling
Updated: 1/11/2018
Celldex Investigational Site
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Phase II Study of Rindopepimut (CDX-110) in Patients With Glioblastoma Multiforme
A Phase II Study of CDX-110 With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme
Status: Enrolling
Updated:  1/11/2018
Celldex Investigational Site
mi
from
Houston, TX
Phase II Study of Rindopepimut (CDX-110) in Patients With Glioblastoma Multiforme
A Phase II Study of CDX-110 With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme
Status: Enrolling
Updated: 1/11/2018
Celldex Investigational Site
mi
from
Houston, TX
Click here to add this to my saved trials
Phase II Study of Rindopepimut (CDX-110) in Patients With Glioblastoma Multiforme
A Phase II Study of CDX-110 With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme
Status: Enrolling
Updated:  1/11/2018
Celldex Investigational Site
mi
from
San Antonio, TX
Phase II Study of Rindopepimut (CDX-110) in Patients With Glioblastoma Multiforme
A Phase II Study of CDX-110 With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme
Status: Enrolling
Updated: 1/11/2018
Celldex Investigational Site
mi
from
San Antonio, TX
Click here to add this to my saved trials
Phase II Study of Rindopepimut (CDX-110) in Patients With Glioblastoma Multiforme
A Phase II Study of CDX-110 With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme
Status: Enrolling
Updated:  1/11/2018
Celldex Investigational Site
mi
from
Salt Lake City, UT
Phase II Study of Rindopepimut (CDX-110) in Patients With Glioblastoma Multiforme
A Phase II Study of CDX-110 With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme
Status: Enrolling
Updated: 1/11/2018
Celldex Investigational Site
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Phase II Study of Rindopepimut (CDX-110) in Patients With Glioblastoma Multiforme
A Phase II Study of CDX-110 With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme
Status: Enrolling
Updated:  1/11/2018
Celldex Investigational Site
mi
from
Charlottesville, VA
Phase II Study of Rindopepimut (CDX-110) in Patients With Glioblastoma Multiforme
A Phase II Study of CDX-110 With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme
Status: Enrolling
Updated: 1/11/2018
Celldex Investigational Site
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Phase II Study of Rindopepimut (CDX-110) in Patients With Glioblastoma Multiforme
A Phase II Study of CDX-110 With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme
Status: Enrolling
Updated:  1/11/2018
Celldex Investigational Site
mi
from
Seattle, WA
Phase II Study of Rindopepimut (CDX-110) in Patients With Glioblastoma Multiforme
A Phase II Study of CDX-110 With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme
Status: Enrolling
Updated: 1/11/2018
Celldex Investigational Site
mi
from
Seattle, WA
Click here to add this to my saved trials
Phase II Study of Rindopepimut (CDX-110) in Patients With Glioblastoma Multiforme
A Phase II Study of CDX-110 With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme
Status: Enrolling
Updated:  1/11/2018
Celldex Investigational Site
mi
from
Orange Village, OH
Phase II Study of Rindopepimut (CDX-110) in Patients With Glioblastoma Multiforme
A Phase II Study of CDX-110 With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme
Status: Enrolling
Updated: 1/11/2018
Celldex Investigational Site
mi
from
Orange Village, OH
Click here to add this to my saved trials
Everolimus and Vatalanib in Treating Patients With Advanced Solid Tumors
A Phase I Trial of the mTOR Inhibitor RAD001 in Combination With VEGF Receptor Tyrosine Kinase Inhibitor PTK787/ZK 222584 in Patients With Advanced Solid Tumors
Status: Enrolling
Updated:  1/12/2018
The Mayo Clinic
mi
from
Rochester, MN
Everolimus and Vatalanib in Treating Patients With Advanced Solid Tumors
A Phase I Trial of the mTOR Inhibitor RAD001 in Combination With VEGF Receptor Tyrosine Kinase Inhibitor PTK787/ZK 222584 in Patients With Advanced Solid Tumors
Status: Enrolling
Updated: 1/12/2018
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
MRI-Guided LITT for Treatment Metastatic Brain Tumors
Use of MRI-Guided Laser Induced Thermal Therapy (LITT) for Metastatic Brain Tumors
Status: Enrolling
Updated:  1/15/2018
Methodist Neurological Institute - Department of Neurosurgery
mi
from
Houston, TX
MRI-Guided LITT for Treatment Metastatic Brain Tumors
Use of MRI-Guided Laser Induced Thermal Therapy (LITT) for Metastatic Brain Tumors
Status: Enrolling
Updated: 1/15/2018
Methodist Neurological Institute - Department of Neurosurgery
mi
from
Houston, TX
Click here to add this to my saved trials
Methotrexate Infusion Into the Fourth Ventricle in Children With Malignant Fourth Ventricular Brain Tumors: A Pilot Study
Methotrexate Infusion Into the Fourth Ventricle in Children With Malignant Fourth Ventricular Brain Tumors: A Pilot Study
Status: Enrolling
Updated:  1/17/2018
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Methotrexate Infusion Into the Fourth Ventricle in Children With Malignant Fourth Ventricular Brain Tumors: A Pilot Study
Methotrexate Infusion Into the Fourth Ventricle in Children With Malignant Fourth Ventricular Brain Tumors: A Pilot Study
Status: Enrolling
Updated: 1/17/2018
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Methotrexate Infusion Into the Fourth Ventricle in Children With Malignant Fourth Ventricular Brain Tumors: A Pilot Study
Methotrexate Infusion Into the Fourth Ventricle in Children With Malignant Fourth Ventricular Brain Tumors: A Pilot Study
Status: Enrolling
Updated:  1/17/2018
Children's Memorial Hermann Hospital
mi
from
Houston, TX
Methotrexate Infusion Into the Fourth Ventricle in Children With Malignant Fourth Ventricular Brain Tumors: A Pilot Study
Methotrexate Infusion Into the Fourth Ventricle in Children With Malignant Fourth Ventricular Brain Tumors: A Pilot Study
Status: Enrolling
Updated: 1/17/2018
Children's Memorial Hermann Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Neoadjuvant Chemotherapy With or Without Second-Look Surgery Followed by Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Intracranial Germ Cell Tumors
A Phase II Study To Assess The Ability Of Neoadjuvant Chemotherapy Plus/Minus Second Look Surgery To Eliminate All Measurable Disease Prior To Radiotherapy For NGGCT
Status: Enrolling
Updated:  1/17/2018
Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham
mi
from
Birmingham, AL
Neoadjuvant Chemotherapy With or Without Second-Look Surgery Followed by Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Intracranial Germ Cell Tumors
A Phase II Study To Assess The Ability Of Neoadjuvant Chemotherapy Plus/Minus Second Look Surgery To Eliminate All Measurable Disease Prior To Radiotherapy For NGGCT
Status: Enrolling
Updated: 1/17/2018
Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Neoadjuvant Chemotherapy With or Without Second-Look Surgery Followed by Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Intracranial Germ Cell Tumors
A Phase II Study To Assess The Ability Of Neoadjuvant Chemotherapy Plus/Minus Second Look Surgery To Eliminate All Measurable Disease Prior To Radiotherapy For NGGCT
Status: Enrolling
Updated:  1/17/2018
Phoenix Children's Hospital
mi
from
Phoenix, AZ
Neoadjuvant Chemotherapy With or Without Second-Look Surgery Followed by Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Intracranial Germ Cell Tumors
A Phase II Study To Assess The Ability Of Neoadjuvant Chemotherapy Plus/Minus Second Look Surgery To Eliminate All Measurable Disease Prior To Radiotherapy For NGGCT
Status: Enrolling
Updated: 1/17/2018
Phoenix Children's Hospital
mi
from
Phoenix, AZ
Click here to add this to my saved trials